Stock Market Reviews

HOLX (Hologic, Inc.) News

Get the latest news, insights, and market updates on HOLX (Hologic, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• 1 S&P 500 Stock Worth Your Attention and 2 We Avoid
  The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
  Dec 16, 2025 - $HOLX
• Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
  MARLBOROUGH, Mass., December 16, 2025--Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
  Dec 16, 2025 - $HOLX
• 3 Cash-Producing Stocks We Approach with Caution
  Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
  Dec 12, 2025 - $HOLX
• Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
  Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
  Dec 12, 2025 - $HOLX
• What Is Driving Hologic's Strength in the US Diagnostics Market?
  HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.
  Dec 12, 2025 - $HOLX
• Is Hologic Stock Outperforming the Nasdaq?
  While Hologic has underperformed the Nasdaq over the past year, it has notably outperformed in recent months, but analysts still remain cautious about the stock’s prospects.
  Dec 12, 2025 - $HOLX
• HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?
  Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.
  Dec 8, 2025 - $HOLX
• 1 Mooning Stock on Our Watchlist and 2 Facing Headwinds
  Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
  Dec 8, 2025 - $HOLX
• US Loses Financing Edge as Asia Borrows in Euros: Credit Weekly
  Asia Pacific borrowers increased euro‑denominated issuance to a record 23% of the total across both currencies this year, up six percentage points from 2024, according to Bloomberg-compiled data. Multiple Asian deals ranked as the most oversubscribed in Europe’s publicly syndicated debt market during their launch week, the data showed. US dollar deals still make up the majority of financing deals, and borrowing in the greenback is up 29% by Asian issuers this year.
  Dec 6, 2025 - $HOLX
• Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions
  HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.
  Dec 4, 2025 - $HOLX